Title:
ビタミンＤ化合物およびワックス状担体を含有する制御放出性経口組成物
Document Type and Number:
Japanese Patent JP6530028
Kind Code:
B2
Abstract:
The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.
Inventors:
Bishop Charles W
Tabash Samil Pea
Agdoau Sammy A
White Jay A
Crawford Keith H
Messner Eric Jay
Petkovic P Martin
Tabash Samil Pea
Agdoau Sammy A
White Jay A
Crawford Keith H
Messner Eric Jay
Petkovic P Martin
Application Number:
JP2017194134A
Publication Date:
June 12, 2019
Filing Date:
October 04, 2017
Export Citation:
Assignee:
Opco Ireland Global Holdings Limited
Opcoral Limited Liability Company
Opcoral Limited Liability Company
International Classes:
A61K31/593; A61K31/663; A61K33/26; A61K45/00; A61P13/12
Domestic Patent References:
| JP2006514695A | ||||
| JP7501343A |
Other References:
C.Bagnis et al,Ital J Mineral Electrolyte Metab,1998年 9月,12(3-4),p.73-76
Attorney, Agent or Firm:
Shinichiro Tanaka
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori